Skip to content

Everest Bipolar Cutting Forceps and Gyrus Bipolar Cutting Forceps

by Gyrus Medical, Inc.

510(k) K023492

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

8 ongoing

This device is named in the recall

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 22 Oct 2026. What this means

Regulatory status

as of registry sync 22 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Special NumberK023492 Date13 Nov 2002ClearedStatusActive

Recalls

8 recalls · 8 ongoing · FDA

  • 5 recalls, same reason

    • Ongoing Z-1642-2026 FDA Class II initiated 25 Feb 2026
    • Ongoing Z-1644-2026 FDA Class II initiated 25 Feb 2026
    • Ongoing Z-1643-2026 FDA Class II initiated 25 Feb 2026
    • Ongoing Z-1639-2026 FDA Class II initiated 25 Feb 2026
    • Ongoing Z-1638-2026 FDA Class II initiated 25 Feb 2026

    Olympus identified that the Cutting Forceps contain components for which the supplier did not adequately validate the welding process. Defective welds can result in the Cutting Forceps' jaw breaking during clinical use.

  • 3 recalls, same reason

    • Ongoing Z-2541-2024 FDA Class II initiated 1 Jul 2024
    • Ongoing Z-2540-2024 FDA Class II initiated 1 Jul 2024
    • Ongoing Z-2542-2024 FDA Class II initiated 1 Jul 2024

    Fractures and breakages in packaging trays and Tyvek covers, which may result in a sterility breach

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

510(k) Number
FDA Product Code
GEI
Device Class
Class II
Regulation
21 CFR Part 878.4400
Advisory Committee
General, Plastic Surgery
FDA Decision
SESE Substantially Equivalent

Other devices from Gyrus Medical, Ltd.

See all devices from Gyrus Medical, Ltd. →